At 6 months, there was an absolute reduction of 8.5% in leaflet thrombosis with edoxaban; but this difference did not reach statistical significance.
← all excerpts
Subclinical Leaflet Thrombosis and Subclinical Aortic Valve Complex Thrombosis in TAVR.
1
—
—